Perbak Capital Partners »

Vertex Pharmaceuticals Incorporated shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Perbak Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $676k 1.7k 391.64
2024-06-30 $1.3M 2.8k 468.72

More positions owned by Perbak Capital Partners

Select Sector Spdr Tr Indl (XLI)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Series Trust S&p Ins Etf (KIE)
Select Sector Spdr Tr Technology (XLK)
Elanco Animal Health (ELAN)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Financial (XLF)
Ubs Group SHS (UBS)
Qiagen Nv Com Shs (QGEN)
D.R. Horton (DHI)
Mettler-Toledo International (MTD)

View all positions for Perbak Capital Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated